DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Entereg (Alvimopan) - Published Studies

 
 



Entereg Related Published Studies

Well-designed clinical trials related to Entereg (Alvimopan)

A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain. [2011.02]

A randomized, placebo-controlled phase 3 trial (study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain. [2011.02]

Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis. [2010.09]

Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway. [2008.11]

Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study. [2008.08.01]

Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain. [2008.07.15]

Postoperative ileus-related morbidity profile in patients treated with alvimopan after bowel resection. [2007.04]

Other research related to Entereg (Alvimopan)

Economic analysis of alvimopan for prevention and management of postoperative ileus. [2012]

The effect of alvimopan on recovery after laparoscopic segmental colectomy. [2011.06]

Alvimopan use in laparoscopic and open bowel resections: clinical results in a large community hospital system. [2010.11]

Alvimopan Use in Laparoscopic and Open Bowel Resections: Clinical Results in a Large Community Hospital System(November). [2010.09.21]

The effects of a short course of antibiotics on alvimopan and metabolite pharmacokinetics. [2010.03]

Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooled responder analysis. [2010]

Economic analysis of alvimopan in North American Phase III efficacy trials. [2009.08.01]

Alvimopan for postoperative ileus. [2009.07.15]

Management of postoperative ileus: focus on alvimopan. [2008.10]

Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus. [2008.06]

Clinical trial: alvimopan for the management of postoperative ileus after abdominal surgery: results of an international randomised, double-blind, multicentre, placebo-controlled clinical study. [2008.03.28]

Mosapride in gastrointestinal disorders. [2008]

Alvimopan accelerates gastrointestinal recovery after bowel resection regardless of age, gender, race, or concomitant medication use. [2007.10]

Alvimopan: a peripherally acting mu-opioid receptor antagonist. [2007.09]

Patterns of gastrointestinal recovery after bowel resection and total abdominal hysterectomy: pooled results from the placebo arms of alvimopan phase III North American clinical trials. [2007.07]

Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. [2007.03]

Meta-analysis: Alvimopan vs. placebo in the treatment of post-operative ileus. [2007.01.01]

Other possibly related research studies

Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study. [2010.03]

Pharmacologic options to prevent postoperative ileus. [2009.09]

Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability. [2009.06]

Pharmacological management of postoperative ileus. [2009.04]

Opioid receptors in the gastrointestinal tract. [2009.06.05]

Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. [2009.04.04]

New approaches to the treatment of opioid-induced constipation. [2008.08]

Efficacy and safety of mu-opioid antagonists in the treatment of opioid-induced bowel dysfunction: systematic review and meta-analysis of randomized controlled trials. [2008.09]

[News from the cochrane library: mu opioid antagonists for opioid-induced bowel dysfunction] [2008.09]

Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus. [2008.09]

Mu-opioid antagonists for opioid-induced bowel dysfunction. [2008.04.16]

Gateways to clinical trials. [2008.01]

New therapies in the treatment of postoperative ileus after gastrointestinal surgery. [2008.01]

Gateways to clinical trials. [2007.10]

The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor. [2008.01]

Gateways to clinical trials. [2007.09]

Opioid-induced bowel dysfunction. [2008.01]

Emerging pharmacologic options for treating postoperative ileus. [2007.10.15]

Mu opioid receptor antagonists: recent developments. [2007.11]

Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review. [2007.11]

Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. [2007]

Cancer-related constipation. [2007.07]

Gateways to clinical trials. [2007.04]

Novel and alternative therapies for childhood constipation. [2007.06]

Treatment of opioid-induced gut dysfunction. [2007.02]

Current and future therapies for chronic constipation. [2011.02]

Opioid-induced constipation: challenges and therapeutic opportunities. [2011.05]

Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects. [2010.10]

Novel opioid antagonists for opioid-induced bowel dysfunction. [2011]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014